Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Post of the year candidate.
Same to you Tonneke. Happy Easter weekend to the LONGS.
Someone was smart and lucky to grab that many at this PPS.
There, happy? GLTU.
Many have had the same experiences when loading and the ticker shows as sells. Either a glitch in the system or what they want the world to see. Who knows?
Finally, a reasonable non panicking post. WAY to many bears in this park.
Great question PhD. I know that is a rhetorical question, but I have no clue. I wish I was around when they commercialized Medistem, I might have a better idea. How did they do it back then?
My GUESS.... They are laser focused on doing what they are doing to get CaverStem FemCelz up and running with enough doctors to provide the services and then the gloves will come off.
IMO, much of what we crave, the corporate spokesman with a vision, the TV commercials, customer testimonials etc are all coming, but a blitz now would be too early. Customers don’t have a place to go. It’s like the Black Friday ad for a $50 80 inch 4K TV and everyone sleeps in front of the store all night to find they only had ONE.
CELZ is just getting off the ground. The PPS blows...... I know it, you know it, the company knows it.
The OTC is unpredictable. Just the buzz with all of this could have us at .10, or it can fall on deaf ears and put us where we are, sub penny. You know as well as I do that some shit azz stocks run into the quarters on almost nothing. Why not CELZ? I have no clue.
What I do feel strongly about is that they have been down this road before and know what they are doing. How the market reacts is largely out of their control, but when the proper infrastructure is done (trial paper, enough locations, enough trainers, hurdles jumped in Russia etc) the gloves will come off.
IMO, the science is there, the efficacy is there, the demand is there, and with the opioid crisis if full swing, anything that is a proven treatment that is NOT a drug is in the right spot at the right time.
Back in July I felt we would settle .04+ and keep moving, but we lost the momo when the offices did not open in time and CaverStem 2.0 needle was introduced... the OTC flippers and dilution killed the PPS, but many are now reloaded for the real run. I would call it a false start.
My current thoughts.... bail out and run for the hills if you think it’s a scam or mismanaged. Or add and these ridiculous prices and wait for the infrastructure to be in place and for the gloves to come off. CELZ has many adversaries, and they know it and are prepared for it. But hey, that is just me. To each their own.
Good point Miggy. Some I know have their averages nice and low now.... :)
Great point. I would be surprised not to see one. They know what they are building. ;)
Some longs hoping for a deal of deals!!!!
Fully agree we are being held down brother. Dark forces or a plan? We may never know
The FDA does not regulate medical procedures performed by qualified and licensed doctors. CaverStem has the only clinically proven procedure to treat Erectile Dysfunction with adult stem cells in the US. CaverStem ONLY uses your own adult stem cells (not Embryonic stem cells) and they are not altered, manipulated or stored. Therefore, FDA does not object to these procedures.
CaverStem has been shown to be effective even in patients who do not respond to PDE5 inhibitors. CaverStem is safe.
Several doctors in the US have been vetted and signed and are now OPEN and treating patients (Doctors Gershman, Said, Bieri, Liu, Narayan, Niemczyk and Sanderson). Currently you can make an appointment any of those locations along with Dr. Antonini in Rome, Italy.
CELZ added physicians in Hawaii (Sanderson), California, Ohio, Texas and Tennessee (to be named soon) and CELZ will continually add the new physicians to the CaverStem™ website as they come aboard.
To speed up new physician training due to demand, CELZ added additional medical personnel to travel to each physicians office to train.
Due to the increased international demand and to compliment the existing relationship with Scott Shea, Thomas Bianchi has joined the company as the international sales representative.
Over 50 domain names have been registered showing that MANY more doctors are being vetted or have shown interest. These includes MANY cities and states in the USA, and now we KNOW there are domains registered in Russia (PromoMed, Dr. Pushkar), Germany, France, Switzerland (Alto Uro, Dr. Bachmann) and Austria.
CaverStem has begun a series of mailer and email campaigns introducing the CaverStem procedure to licensed physicians in the areas of urology, sexual function and plastic surgery. This campaign which will be expanded on a monthly basis with follow up mailers and emails and calls from our sales representatives. It's the goal to reach out to a minimum of 2500 new physicians each month by these methods. CaverStem reported good replies from the January emails.
CaverStem has also increased its online presence on Social Media and by placing banner advertising on websites and search engines attracting the active male. They are currently scripting television commercials which will be edited to direct patients to each physician in their area.
U.S. and international agreements have been reached for exclusive distribution rights for the FDA approved Generation 2 bone marrow harvest technology which has been used with multiple ED patients with excellent results, however Government exemptions are required for the ongoing import of the device in Russia. This is a slow and tedious process in getting approval, therefore CELZ progress has been delayed in Russia.
Your DD will show that Dr. Gershman has been performing the procedure with EXCELLENT results…Up to 90% success rate, even in difficult patients. CELZ has received positive feedback from treating physicians of a 70% to 90% efficacy in their patients. Obviously results differ depending on the age and health of the patient and cause and severity of their erectile dysfunction.
A one-year trial has concluded and will PROVE the same results and you can watch it here; https://clinicaltrials.gov/ct2/show/NCT03699943?recrs=deghi&fund=2&lupd_s=09%2F27%2F2018&lupd_d=14
Please review this. CELZ is working on their paper for publication. This is ongoing and in compliance with contractual obligations. Once the paper has been approved by The Journal of Translational Medicine and a publication date advised, shareholders will be updated. Additionally, CELZ has designed an electronic patient registry that is intended to include data from the clinical trial, data from treating physicians using centrifuge technology with a 30cc to 60cc bone marrow aspiration and the second generation, needle only.
Revenue has now started, CMTH is cash flowing. Additional physicians are scheduled for training, patients are being treated and revenues are being generated and increasing each month. CMTH anticipates reaching financial self-sufficiency by revenues from sales in 2019.
CMTH has Institutional Investors now, slowing dilution and providing much better terms as CMTH completes the commercialization phase. The most recent notes that were issued in 2018 were renegotiated providing cash for operations.
CaverStem signed with PatientGain to redesigning the website for the anticipated HUGE volume of traffic CaverStem will generate. This has generated many calls to the vetted doctors.
CMTH has started commercializing and scheduling patients for the FemCelz procedure for the treatment of female sexual dysfunction using stem cells from the patient's own bone marrow. Many of the existing CaverStem affiliated physician's will also treat female patients for sexual function and we anticipate that they will be the leaders in progressing the FemCelz program.
CMTH anticipates acquiring the Virility Centers of America brand from affiliate company Creative Medical Health, Inc. The use of the Virility Centers brand is related to male and female wellness clinics, including sexual function (CaverStemTM and FemCelzTM), incontinence and infertility. This brand will compliment the CaverStem and FemCelz brands.
CaverStem and FemCelz are just TWO of SEVERAL patents held by CMTH.
4 NEW patents were applied for in 2018.
Gershman and Ichim have already successfully commercialized Medistem.
CaverStem, FemCelz, StemSpine & AmnioStem have all be TRADEMARKED
CaverStem is now a REGISTERED TRADEMARK. Caverstem®
We KNOW Caverstem® + FemCelz + StemSpine + AmnioStem = NASDAQ
PLEASE read the sticky posts seen when logging in to iHub through a browser!!
Note holders and flippers. Longs are adding what they can!
Same her CP. Uncle Sam snatched up my dry powder. I will add ASAP. So bummed to miss these prices. Hopefully C2 will be right and I can add at .0001.........LOL
+1. Like I said buddy, the new posters here tells the tale :)
No luck needed Miggy, just patience as they put it all together. It’s right there in front of anyone who wants to look.
Spot on Chaka.
Great DD sir.
Great thoughts rrao11.
No argument from me. It’s still forward progress at least. It’s all coming together IMO whether we like the video quality or not. Like someone else posted, it will be nice when we see a nice corporate video saying, “Hi, I’m so and so, and this is my company and my vision. Etc etc “. We will get there.
Interesting article from 2016, now coming to fruition at at CELZ doctor near you...... :)
https://www.yahoo.com/tech/stem-cell-treatment-could-help-182153568.html?soc_src=newsroom&soc_trk=com.apple.UIKit.activity.CopyToPasteboard&.tsrc=newsroom
So is the PPS.
Actually that stock doesn’t even sell pot, they sell CBD from hemp. Pot legalization was really not good for CBD sales that were already legal. But any way, the point was to show that when the spring is wound tight it can uncoil fast and furious. You are right, the trial results could do it, or so could any of many more things IMO.
At this point the SS is different too, but again, it was just to show what can happen when things line up as news events start happening is all.
$CELZ
Carm... in case you forgot anything..... The FDA does not regulate medical procedures performed by qualified and licensed doctors. CaverStem has the only clinically proven procedure to treat Erectile Dysfunction with adult stem cells in the US. CaverStem ONLY uses your own adult stem cells (not Embryonic stem cells) and they are not altered, manipulated or stored. Therefore, FDA does not object to these procedures.
CaverStem has been shown to be effective even in patients who do not respond to PDE5 inhibitors. CaverStem is safe.
Several doctors in the US have been vetted and signed and are now OPEN and treating patients (Doctors Gershman, Said, Bieri, Liu, Narayan, Niemczyk and Sanderson). Currently you can make an appointment any of those locations along with Dr. Antonini in Rome, Italy.
CELZ added physicians in Hawaii (Sanderson), California, Ohio, Texas and Tennessee (to be named soon) and CELZ will continually add the new physicians to the CaverStem™ website as they come aboard.
To speed up new physician training due to demand, CELZ added additional medical personnel to travel to each physicians office to train.
Due to the increased international demand and to compliment the existing relationship with Scott Shea, Thomas Bianchi has joined the company as the international sales representative.
Over 50 domain names have been registered showing that MANY more doctors are being vetted or have shown interest. These includes MANY cities and states in the USA, and now we KNOW there are domains registered in Russia (PromoMed, Dr. Pushkar), Germany, France, Switzerland (Alto Uro, Dr. Bachmann) and Austria.
CaverStem has begun a series of mailer and email campaigns introducing the CaverStem procedure to licensed physicians in the areas of urology, sexual function and plastic surgery. This campaign which will be expanded on a monthly basis with follow up mailers and emails and calls from our sales representatives. It's the goal to reach out to a minimum of 2500 new physicians each month by these methods. CaverStem reported good replies from the January emails.
CaverStem has also increased its online presence on Social Media and by placing banner advertising on websites and search engines attracting the active male. They are currently scripting television commercials which will be edited to direct patients to each physician in their area.
U.S. and international agreements have been reached for exclusive distribution rights for the FDA approved Generation 2 bone marrow harvest technology which has been used with multiple ED patients with excellent results, however Government exemptions are required for the ongoing import of the device in Russia. This is a slow and tedious process in getting approval, therefore CELZ progress has been delayed in Russia.
Your DD will show that Dr. Gershman has been performing the procedure with EXCELLENT results…Up to 90% success rate, even in difficult patients. CELZ has received positive feedback from treating physicians of a 70% to 90% efficacy in their patients. Obviously results differ depending on the age and health of the patient and cause and severity of their erectile dysfunction.
A one-year trial has concluded and will PROVE the same results and you can watch it here; https://clinicaltrials.gov/ct2/show/NCT03699943?recrs=deghi&fund=2&lupd_s=09%2F27%2F2018&lupd_d=14
Please review this. CELZ is working on their paper for publication. This is ongoing and in compliance with contractual obligations. Once the paper has been approved by The Journal of Translational Medicine and a publication date advised, shareholders will be updated. Additionally, CELZ has designed an electronic patient registry that is intended to include data from the clinical trial, data from treating physicians using centrifuge technology with a 30cc to 60cc bone marrow aspiration and the second generation, needle only.
Revenue has now started, CMTH is cash flowing. Additional physicians are scheduled for training, patients are being treated and revenues are being generated and increasing each month. CMTH anticipates reaching financial self-sufficiency by revenues from sales in 2019.
CMTH has Institutional Investors now, slowing dilution and providing much better terms as CMTH completes the commercialization phase. The most recent notes that were issued in 2018 were renegotiated providing cash for operations.
CaverStem signed with PatientGain to redesigning the website for the anticipated HUGE volume of traffic CaverStem will generate. This has generated many calls to the vetted doctors.
CMTH has started commercializing and scheduling patients for the FemCelz procedure for the treatment of female sexual dysfunction using stem cells from the patient's own bone marrow. Many of the existing CaverStem affiliated physician's will also treat female patients for sexual function and we anticipate that they will be the leaders in progressing the FemCelz program.
CMTH anticipates acquiring the Virility Centers of America brand from affiliate company Creative Medical Health, Inc. The use of the Virility Centers brand is related to male and female wellness clinics, including sexual function (CaverStemTM and FemCelzTM), incontinence and infertility. This brand will compliment the CaverStem and FemCelz brands.
CaverStem and FemCelz are just TWO of SEVERAL patents held by CMTH.
4 NEW patents were applied for in 2018.
Gershman and Ichim have already successfully commercialized Medistem.
CaverStem, FemCelz, StemSpine & AmnioStem have all be TRADEMARKED
CaverStem is now a REGISTERED TRADEMARK. Caverstem®
We KNOW Caverstem® + FemCelz + StemSpine + AmnioStem = NASDAQ
PLEASE read the sticky posts seen when logging in to iHub through a browser!!
Spot on Georgie!!!
I can clear it up doc. This is what he is trying to say in total....
-Patel and Ichim are irrelevant to the company and just churn out meaningless patents that have no bearing.
-The alleged patents are dead.
-The company trademarked many of their scam treatments to make them look legit, but that has no bearing that the treatments are real.
-It matters not to CMTH that that Ichim, Gershman and Warbington were associated to Medistem.
-CMH was at one time a Delaware Corp, but is no longer, therefore CMH has dissolved and is no longer a legal entity.
-Since CMTH is linked to CMH, therefore CMTH is not a legal entity.
-The company no longer occupies or uses the Peoria address, but the address lingers on many documents is further proof that the company is illegitimate.
-The company uses the CEO’s residential address, but the address is not registered to the CEO proving the company is a scam.
-TW was associated with another company that was involved in a lawsuit, so everything else about him is suspect.
-There is no evidence that any of the patented stem cell treatments work.
-CMTH, being an illegitimate company, is nothing more that a share selling scheme that duped several doctors into participating.
-Some of the treating doctors at one time in their career had a complaint filed on them, so anything they do now is suspect, and they may have not been duped into CMTH, they may be complicit in the scheme.
-The trial results registered on the .gov website is a sham, and therefore the results came out poor and CMTH his purposefully hiding the results by not issuing their joint paper while they dilute as many shares as possible. Dr. Rajfer being the Principal Investigator is irrelevant and the fact that medical trials are heavily regulated is meaningless.
-To perpetuate the scheme, one of the scheming doctors has showed a picture of boxes and lied about them being Caverstem kits and there is no evidence that CMTH sells them at all.
-To perpetuate the scheme even further, some of the participating doctors posted images of fake newspaper advertising and/or images of them with CaverStem photo boards. In fact, the newspaper, if it were real, would run in a small town with below average income and the residents cannot afford CaverStem or FemCelz.
-Even though there is no evidence that CMTH has anything of value, and no evidence that they are providing $1600.00 harvest kits, even if they were selling kits, they are just sourcing inexpensive biopsy kits, providing further evidence of the scheme.
-All of this and more is flying under the radar of the regulators and authorities because the OTC just has too many scams to police, but he plans to call the AZ AG and other regulators (post 76065) to get justice and is working tirelessly to warn off uneducated investors.
Why on God’s green earth are we rambling about addresses and silly stuffium?
Maybe we will catch on the next good stock. I know you won’t hang around a snake oil salesmen stock.
Great post Gob
It will still be much more than Q4 and show a nice percentage increase.
They ran lean and mean in some ways....
Operating Expenses 2017: $1,174,606
Operating Expenses 2018: $1,168,250
Clear as a bell!
ZERO chances of .005. I know way too many longs that would sell a kidney if it even got anywhere close, probably even the .008’s. Wayyyy too much brewing right now. Big revenue is just weeks away from being shown. Too many things can pop any time.
Nice post NSX, I will stay here to and bug you all the way to dollars. I am sure CP and a few others will be here too :)
Hey Corbink. I held both of those too and did the same thing. Sold both and went all in here. This is the best OTC out there right now. As xxx bricate pointed out, we had a false start and stumbled whe we had some delays. Right now it’s all lining back up, and all the things we learned about last year have come true. The offices are opening and the patients are being helped. We just need to get back on our feet and get the mojo back. When that happens, I agree, it will way out perform the other tickers. Way too much happening here.
That trigger may come any time, but the Q1 will surprise many. I am adding whenever I can at this silly PPS.
$CELZ